News

While GitLab took a beating from its Q2 sales guidance downgrade, the statistical backdrop of GTLB stock presents an enticing ...
Going back to PLTR stock, its trailing-two-month price action can be converted as a 4-6-U sequence. Based on past analogs, we ...
CSL Behring Germany today announced that the first haemophilia B patient in Germany was treated with the gene therapy HEMGENIX® (etranacogene dezaparvovec) at the Hemophilia Treatment Center at ...